In some cases, immune cells in the lungs can contribute to worsening a virus attack. In a new study, researchers at Karolinska Institutet in Sweden describe how immune cells called macrophages develop in the lungs and which ...
Jan 4, 2021
0
128
NTMs are closely related to tuberculosis bacteria and can (but do not need to) cause infectious diseases in humans. They are called "nontuberculous mycobacteria" (NTMs) to distinguish them from tuberculosis bacteria. There ...
Jul 13, 2020
0
3
As we return to some degree of normalcy after weeks of social distancing, we all need a plan. As an immunologist, I've given this a lot of thought personally and professionally.
May 25, 2020
0
35
People with the most severe forms of COVID-19 are often older and have existing health problems. About 10% of COVID-19 patients have heart disease, diabetes and high blood pressure. Yet surprisingly, people with lung disease, ...
Apr 28, 2020
0
3
(HealthDay)—The woman worked in the airlines industry and was in her late 50s. She arrived at Henry Ford Health System in Detroit with a cough, fever and mental confusion that had arisen over the prior three days.
Apr 2, 2020
0
39
Epidemiologists at The University of Manchester have discovered an association between the number of prescriptions for antibiotics and a higher risk of hospital admissions.
Mar 2, 2020
0
2
The strength of the immune system in response to respiratory infections is constantly changing, depending on the history of previous, unrelated infections, according to new research from the Crick.
Jan 13, 2020
0
39
A new approach to treating people with cystic fibrosis (CF) has been shown to reduce inflammation, which has the potential to reduce the need for lung transplants and lower the risk of death.
Dec 3, 2019
0
2
Many admissions to the intensive care unit may be preventable, potentially decreasing health care costs and improving care, according to new research published online in the Annals of the American Thoracic Society.
Oct 4, 2019
0
1
Taking a low dose of the antibiotic azithromycin for six months reduces symptoms for patients with the chronic lung condition primary ciliary dyskinesia (PCD), according to research presented at the European Respiratory Society ...
Oct 2, 2019
0
1
